15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering Blend Labs Inc, 3 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets range widely, $1.90 to $4.50 (about 2.4x), a sign of real disagreement on valuation. The average target of $3.28 sits 87% above the current $1.75. The rating mix has stayed broadly stable, with Buy-side ratings easing from 5 to 3 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.01 next quarter toward $0.10 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Moderate Buy
Strong Buy00%
Buy360%
Hold240%
Sell00%
Strong Sell00%
Based on 5 analysts giving stock ratings to Blend Labs Inc.
As of Jul, 3 of 5 firms rate BLND a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
BLND EPS & revenue forecast
EPS · NEXT QUARTER
$0.01
Range $0.01 – $0.02 · 5 analysts · -32% YoY
Next period, 5 analysts expect Blend Labs Inc to earn $0.01 a share (range $0.01 – $0.02), versus $0.02 a year earlier. Full-year consensus is $0.05, growing to $0.10 the year after.
REVENUE · NEXT QUARTER
$34.2M
Range $33.9M – $34.5M · 5 analysts · +4% YoY
Revenue is expected to reach $34.2M (range $33.9M – $34.5M), +4.0% year-over-year. Full-year consensus is $131.6M, rising to $146.7M next year.
Top analysts covering Blend Labs Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BLND.
#1
Joseph Vafi
Canaccord Genuity · Rank #316
Buy
$4.50+156.4% to target
Overall win rate
32%
+ Follow
#2
RT
Ryan Tomasello
Keefe, Bruyette & Woods
Hold
$1.90+8.3% to target
Coverage
—
+ Follow
#3
Karl Keirstead
UBS
Hold
$2.00+14.0% to target
Coverage
—
+ Follow
#4
Michael Turrin
Wells Fargo
Buy
$4.00+127.9% to target
Coverage
—
+ Follow
#5
AK
Aaron Kimson
Citizens
Buy
$4.00+127.9% to target
Coverage
—
+ Follow
BLND stock forecast FAQ
What is BLND's average 12-month price target?+
The 5 analysts with a live target average $3.28 for Blend Labs Inc over the next 12 months, ranging from a $4.50 high to a $1.90 low.
Is BLND stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 5 analyst ratings, 3 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for BLND?+
The Street-high target is $4.50 (Canaccord Genuity), and the Street-low is $1.90 (Keefe, Bruyette & Woods). The average of all 5 active targets is $3.28.
How many Wall Street analysts cover BLND?+
5 analysts have an active rating on Blend Labs Inc, and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering BLND?+
Among analysts who currently cover BLND, Joseph Vafi of Canaccord Genuity has the strongest overall Quantellect track record (Rank #316). Their current call is Buy with a $4.50 target.
What is Blend Labs Inc's projected EPS for next quarter?+
The consensus estimate is $0.01 per share (range $0.01 – $0.02) across 5 analysts. Full-year EPS is projected at $0.05, rising to $0.10 the following year.
How much revenue is Blend Labs Inc expected to report next quarter?+
Consensus revenue is $34.2M (range $33.9M – $34.5M). Full-year revenue is projected at $131.6M, growing to $146.7M next year.
Have analysts been upgrading or downgrading BLND lately?+
As of Jul, 3 of 5 firms rate BLND a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BLND calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
